Drug Trial Radar · NCT07047365
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
Last checked: Nov 19, 2026Latest source record: Jun 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
416
Planned (sponsor's estimate)
Start
Jul 25, 2025
Primary completion
Jun 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 2, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
TQB2930 is a HER2 bispecific antibody drug. This study aims to evaluate the efficacy and safety of TQB2930 combined with investigator's choice of chemotherapy versus trastuzumab combined with investigator's choice of chemotherapy in subjects with HER2-positive advanced breast cancer who have received at least two prior lines of anti-HER2 therapy in the advanced station.
Conditions
- HER2-positive Advanced Breast Cancer
Interventions
TQB2930+ chemotherapyDrug
TQB2930 injection is a HER2 bispecific antibody drug; Chemotherapy: Capecitabine Tablets, Gemcitabine Hydrochloride for Injection, Vinorelbine Tartrate Injection and Eribulin Mesylate Injection are Chemotherapy Drugs.
Trastuzumab+ chemotherapyDrug
Trastuzumab is a HER2-specific targeted drug; Capecitabine Tablets, Gemcitabine Hydrochloride for Injection, Vinorelbine Tartrate Injection and Eribulin Mesylate Injection are Chemotherapy Drugs.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survival (PFS)Time frame: Baseline up to IRC-assessed Disease Progression(PD), approximately 1 years
Locations
75 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China · Not yet recruiting
Anhui Provincial Hospital( The First Affiliated Hospital of USTC)
Hefei, Anhui, China · Not yet recruiting
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China · Not yet recruiting
The Fifth Medical Center of Chinese People's Liberation Army General Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
Chong Qing University Cancer Hospital
Chongqing, Chongqing Municipality, China · Not yet recruiting
Fuzhou First Generel Hospital Affiliated with Fujian Medical University
Fuzhou, Fujian, China · Not yet recruiting
The First Hospital of Lanzhou University
Lanzhou, Gansu, China · Not yet recruiting
Gansu Cancer Hospital
Lanzhou, Gansu, China · Not yet recruiting
Sun Yat - sen University Cancer Center
Guangzhou, Guangdong, China · Not yet recruiting
Peking University Shenzhen Hospital
Shenzhen, Guangdong, China · Not yet recruiting
The Second Affiliated Hospital of Guangxi University of Science and Technology
Liuzhou, Guangxi, China · Not yet recruiting
Liuzhou People's Hospital
Liuzhou, Guangxi, China · Not yet recruiting
Affiliated Cancer Hospital of Guangxi Medical Universit
Nanning, Guangxi, China · Not yet recruiting
The Affiiated Cancer Hospital of Guizhou Medical University
Guiyang, Guizhou, China · Not yet recruiting
Guizhou Provincial People's Hospital
Guiyang, Guizhou, China · Not yet recruiting
Hainan General Hospital
Haikou, Hainan, China · Not yet recruiting
The First Hospital of Qinhuangdao
Qinhuangdao, Hebei, China · Not yet recruiting
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China · Not yet recruiting
Tangshan People's Hospital
Tangshan, Hebei, China · Not yet recruiting
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China · Recruiting
The First Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China · Not yet recruiting
Jiamusi Tuberculosis Hospital (Jiamusi Tumor Hospital)
Jiamusi, Heilongjiang, China · Not yet recruiting
Mudanjiang Cancer Hospital
Mudanjiang, Heilongjiang, China · Not yet recruiting
AnYang Tumor Hospital
Anyang, Henan, China · Not yet recruiting
The First Affiliated Hospital of Henan University of Science & Technology
Luoyang, Henan, China · Not yet recruiting
Nanyang Second General Hospital
Nanyang, Henan, China · Not yet recruiting
The First Affiliated Hospital of Xinxiang Medical University
Xinxiang, Henan, China · Not yet recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Not yet recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China · Not yet recruiting
Jingmen People's Hospital
Jingmen, Hubei, China · Not yet recruiting
Xiangyang Central Hospital
Xiangyang, Hubei, China · Not yet recruiting
The First People's Hospital of Changde City
Changde, Hunan, China · Not yet recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Not yet recruiting
People's Hospital of Hunan Province
Changsha, Hunan, China · Not yet recruiting
Xiangya Hospital of Central South University
Changsha, Hunan, China · Not yet recruiting
The Central Hospital of Yongzhou
Yongzhou, Hunan, China · Not yet recruiting
Zhangjiajie People's Hospital
Zhangjiajie, Hunan, China · Not yet recruiting
JiangSu Cancer Hosipital
Nanjing, Jiangsu, China · Not yet recruiting
The Affiliated Sir Run Run Hospital of Nanjing Medical University
Nanjing, Jiangsu, China · Not yet recruiting
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China · Not yet recruiting
Showing 40 of 75 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.